Moving Yourself in Space and Time: MYSTIC
Sponsored by Emory University
About this study
This study is being done to answer the question: Do people with Parkinson's benefit from a new stepping therapy, and how do people with Parkinson's best learn new steps and rhythms set to music? Researchers will also compare individuals with Parkinson's Disease with people with Mild Cognitive Impairment, and with people with neither of these conditions. The purpose of this study is to identify principles of human-music interactions to establish underlying guiding theories for application to music-based rehabilitation for older populations with neurodegenerative disease, leading to more refined and targeted music-based rhythmic movement therapies.
This study aims to analyze the effects of an innovative rehabilitation intervention comprising complex rhythmic movement sequence (CRMS) rehabilitation (aka, Spatiotemporal Activity Modification (STEAM)) training for adults. The central hypothesis is that the spatial and temporal components of CRMS are learned at slower rates in mild cognitive impairment (MCI) than in controls, and that CRMS-based rehabilitation strategies can improve cognitive and mobility status in MCI. Researchers hypothesize that people with cognitive impairment or Parkinson's disease (PD) will show reduced capacity and slower responses when modulating their movements to auditory cues encoded within complex musical-rhythmic patterns. Musical rhythm, which includes the timing and pattern of sound in music, can be commu…
Where this study is enrolling
- I'm interested
Emory University, Executive Park, Wesley Woods
Atlanta, Georgia
Who can participate
Inclusion criteria
- ✓for Young adults and adults with normal cognition (NC):
- ✓18 to 35 Years old
- ✓Montreal Cognitive Assessment (MoCA) score of 26 to 30
- ✓Inclusion Criteria for Older Adults:
- ✓50 to 79 with or without MCI
- ✓50 to 79 years old with Parkinson's disease (PD), who do NOT have impaired decision-making capacity
- ✓Participants who achieve less than 150 minutes moderate or 75 minutes vigorous aerobic activity per week (as per the US Department of Health and Human Services (HHS)),
Exclusion criteria
- ✕for all groups:
- ✕Acute medical illness requiring hospitalization;
- ✕Uncontrolled congestive heart failure;
- ✕History of stroke in the past three years;
- ✕Inability to perform study procedures;
- ✕Medical or physical conditions that would preclude participation (e.g., severe arthritis or mobility problems, uncontrolled hypertension or diabetes, renal failure, history of angina with activity);
- ✕On medications that could adversely affect cognition, e.g., antipsychotics, opioids, stimulants, chemotherapy, and neurologic prescriptions to treat Multiple Sclerosis. When applicable, enrollment will be delayed until dosages are stable on e.g., Aricept, Namenda, anticholinesterase inhibitors, for at least 3 months
- ✕Psychotic disorders
- ✕Confounding neurologic conditions \[e.g., active central nervous system (CNS) opportunistic infections, seizure disorders, head injury with loss of consciousness \>30 minutes, intracranial neoplasms, stroke with neurological or neuropsychiatric sequelae\]
- ✕Substance Use Disorder, Major Depressive Disorder, and Generalized Anxiety Disorder within six months of evaluation.
- ✕Inability to provide informed consent
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.